Morphine drugs market to reach $30.17 billion by 2030 at 5.3% CAGR, driven by increasing prevalence of chronic pain conditions.
Read More
Lyophilized injectable drugs market to reach $4.87 billion by 2030 at 4.2% CAGR, driven by rising incidence of cardiac disorders.
Read More
The global montelukast sodium market to reach $6.33 billion by 2030 at 8.4% CAGR, driven by increasing prevalence of asthma.
Read More
Lymphocyte activating gene 3 (lag3) antibody market to reach $1.53 billion by 2030 at 13.9% CAGR, driven by rising cancer incidence.
Read More
Monoclonal antibody therapeutics market to reach $396.1 billion by 2030 at 11.9% CAGR, driven by rising prevalence of autoimmune diseases.
Read More
Lyme disease vaccine market to reach $1.57 billion by 2030 at 7.0% CAGR, driven by increasing prevalence of lyme disease and rising healthcare expenditure.
Read More
Lung cancer drugs market to reach $88.06 billion by 2030 at 10.9% CAGR, driven by rising prevalence rate of lung cancer.
Read More
Monoclonal antibodies market to reach $464.39 billion by 2030 at 12.6% CAGR, driven by increasing prevalence of cost-efficient biosimilar monoclonal antibodies.
Read More
Lumbosacral radicular pain management market to reach $1.17 billion by 2030 at 5.4% CAGR, driven by rising prevalence of back pain disorders.
Read More
Molecular targeted therapy market to reach $107.64 billion by 2030 at 8.4% CAGR, driven by rise of personalized medicine.
Read More